Did You File a Claim Against Purdue Pharma as Part of its Bankruptcy Proceeding? Do You have a Claim Against Purdue Pharma's Owners?
PR90140
NEW YORK, June 17, 2021 /PRNewswire=KYODO JBN/ --
- A Hearing to Consider Confirmation of the Chapter 11 Plan May Affect Your
Rights.
- Confirmation Hearing August 9, 2021.
The following statement is being issued by Prime Clerk* regarding the Purdue
Pharma L.P. bankruptcy.
WHAT IS THIS ABOUT?
On June 3, 2021, as part of Purdue Pharma L.P.'s bankruptcy proceedings, the
United States Bankruptcy Court for the Southern District of New York entered an
order called the "Disclosure Statement Order" that:
(a) Authorized Purdue Pharma L.P. and its affiliated debtors and
debtors in possession to solicit acceptances of the Fifth Amended
Joint Chapter 11 Plan of Reorganization of Purdue Pharma L.P. and
Its Affiliated Debtors, which includes (a) releases of any actual
or potential claims against Sackler family members, and certain other
individuals and related entities, relating to Purdue Pharma L.P. and
its affiliated debtors (including Purdue prescription opioids, like
OxyContin, or other prescription opioids manufactured or sold by
Purdue); and (b) an injunction requiring that certain claims against
the released parties be asserted only against trusts established under
the plan;
(b) Approved the Disclosure Statement for Fifth Amended Joint Chapter
11 Plan for Purdue Pharma L.P. and Its Affiliated Debtors as
containing "adequate information" pursuant to section 1125 of the
Bankruptcy Code;
(c) Approved the solicitation materials and documents to be included
in solicitation packages; and
(d) Approved procedures for soliciting, receiving, and tabulating
votes on the plan and for filing objections to the plan.
The Court will consider confirmation of the plan at the Confirmation Hearing.
WHEN IS THE HEARING?
The Confirmation Hearing will be held on August 9, 2021, at 10 a.m., prevailing
Eastern Time, before the Honorable Robert D. Drain, in the United States
Bankruptcy Court for the Southern District of New York, located at 300
Quarropas Street, White Plains, New York 10601-4140. The hearing will be
conducted via Zoom videoconference for those who will be participating in the
Confirmation Hearing(1) if General Order M-543 is still in effect or unless
otherwise ordered by the Bankruptcy Court.
The Confirmation Hearing may be extended and rescheduled by the Court or the
Debtors without further notice by an agenda filed with the Court, and/or by a
Notice of Adjournment filed with the Court and delivered to all parties who are
entitled to notice.
WHAT ARE YOUR OPTIONS?
Vote on the Plan: Your vote must be submitted so it is actually received on or
before July 14, 2021, at 4:00 p.m., prevailing Eastern Time. Detailed
instructions on how to vote are available at PurduePharmaClaims.com or by
calling (844) 217-0912 (toll free) or (347) 859-8093 (international). Failure
to follow instructions properly may disqualify your vote.
Object to the Plan: An objection must be submitted so that it is actually
received on or before July 19, 2021, at 4:00 p.m., prevailing Eastern Time.
Detailed instructions on how to file an objection are available at
PurduePharmaClaims.com or by calling (844) 217-0912 (toll free) or (347)
859-8093 (international).
Allowance Request: If you believe that you hold a claim against Purdue Pharma
L.P. that is not currently entitled to vote but that you believe should be
entitled to vote, you can request the allowance of such claim for voting
purposes. To do so, you must file a motion with the Court on or before July 19,
2021, at 4:00 p.m., prevailing Eastern Time. Detailed instructions on how to
file an allowance request are available at PurduePharmaClaims.com or by calling
(844) 217-0912 (toll free) or (347) 859-8093 (international).
If the plan is confirmed, anyone with an actual or potential claim against
Purdue Pharma L.P. or any of its affiliated debtors, or with an actual or
potential claim against Sackler family members, and certain other individuals
and related entities, relating to Purdue Pharma L.P. and its affiliated debtors
(including Purdue prescription opioids, like OxyContin, or other prescription
opioids manufactured or sold by Purdue), will be bound by the terms of the
plan, including the releases and injunctions contained therein.
This is only a summary. For more information:
-- Call: (844) 217-0912 (toll free) or (347) 859-8093 (international)
-- Visit: PurduePharmaClaims.com
-- Write: Purdue Pharma Ballot Processing, c/o Prime Clerk LLC, One
Grand Central Place, 60 East 42nd Street, Suite 1440, New York, NY 10165
-- Email: purduepharmainfo@primeclerk.com
Please be advised that Prime Clerk LLC is authorized to answer questions about,
and provide additional copies of, solicitation materials, but may not advise
you as to whether you should vote to accept or reject the plan or provide any
legal advice.
(1) Parties or members of the public who wish to participate in the
Confirmation Hearing should consult the Court's calendar with respect to the
day of the Confirmation Hearing at
https://www.nysb.uscourts.gov/calendars/rdd.html for information regarding how
to be added as a participant. Members of the public who wish to listen to, but
not participate in, the Confirmation Hearing free of charge may do so
telephonically at a number to be provided on the Debtors' case website at:
PurduePharmaClaims.com (
).
SOURCE *Prime Clerk the Court-Appointed Claims and Noticing Agent
CONTACT: Michele Sharp +1 (203) 588-7584
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。